APPLICATION
ANDA201006
TYPE
ANDA
ORIGINAL APPROVAL
2011-03-22
LATEST ACTION
2023-12-27
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
LATANOPROSTPrescription
LATANOPROST 0.005% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2023-12-27Labeling · Supplement 16 · standardAP
2021-09-03Labeling · Supplement 13 · standardAP
2020-02-21Labeling · Supplement 8 · standardAP
2015-12-09Labeling · Supplement 6 · standardAP
2013-02-27Labeling · Supplement 4 · standardAP
2011-03-22Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.